Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: a retropective study

BACKGROUND: Penile cancer (PC) is a rare tumor, and therapeutic options are limited for this disease, with an overall 5-year overall survival around 65-70%. Adjuvant therapy is not recommended for patients with N0-1 disease, despite up to 60% of these patients will die within 5 years from diagnosis....

Descripción completa

Detalles Bibliográficos
Autores principales: Di Lorenzo, Giuseppe, Perdonà, Sisto, Buonerba, Carlo, Sonpavde, Guru, Gigantino, Vincenzo, Pannone, Giuseppe, Quarto, Giuseppe, Ferro, Matteo, Gaudioso, Gabriella, Terracciano, Daniela, Di Trolio, Rossella, Rescigno, Pasquale, Botti, Gerardo, De Placido, Sabino, Facchini, Gaetano, Ascierto, Paolo A, Franco, Renato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717121/
https://www.ncbi.nlm.nih.gov/pubmed/23819610
http://dx.doi.org/10.1186/1479-5876-11-161

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717121/
https://www.ncbi.nlm.nih.gov/pubmed/23819610
http://dx.doi.org/10.1186/1479-5876-11-161

Ejemplares similares